# Bicara Therapeutics Inc.: Form SCHEDULE 13D/A, filed Mar 2, 2026

- Company: [Bicara Therapeutics Inc.](/companies/bcax.md) (CIK 2023658)
- Form: SCHEDULE 13D/A
- Filed: 2026-03-02
- Accepted by EDGAR: Mar 2, 2026, 16:25 ET
- Period: not reported
- Accession: 0001346824-26-000066
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/2023658/000134682426000066/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/2023658/000134682426000066/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/2023658/000134682426000066/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Mar 2, 2026.
Source: SEC EDGAR, the filing index for accession 0001346824-26-000066. Last ingested by Listed: Nov 10, 2026, 02:09 ET. No prices; not investment advice.
